These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30995757)

  • 1. Clinical and Biological Significance of
    Nagel A; Szade J; Iliszko M; Elzanowska J; Welnicka-Jaskiewicz M; Skokowski J; Stasilojc G; Bigda J; Sadej R; Zaczek A; Markiewicz A
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
    Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
    Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients.
    Tomita S; Zhang Z; Nakano M; Ibusuki M; Kawazoe T; Yamamoto Y; Iwase H
    Cancer Sci; 2009 Jun; 100(6):1012-7. PubMed ID: 19320640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relative Expression of ERα Isoforms ERα66 and ERα36 Controls the Cellular Response to 24R,25-Dihydroxyvitamin D3 in Breast Cancer.
    Verma A; Cohen DJ; Jacobs TW; Boyan BD; Schwartz Z
    Mol Cancer Res; 2021 Jan; 19(1):99-111. PubMed ID: 33082240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.
    Markiewicz A; Wełnicka-Jaśkiewicz M; Skokowski J; Jaśkiewicz J; Szade J; Jassem J; Zaczek AJ
    PLoS One; 2013; 8(8):e72219. PubMed ID: 23951298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
    Pentheroudakis G; Kotoula V; Eleftheraki AG; Tsolaki E; Wirtz RM; Kalogeras KT; Batistatou A; Bobos M; Dimopoulos MA; Timotheadou E; Gogas H; Christodoulou C; Papadopoulou K; Efstratiou I; Scopa CD; Papaspyrou I; Vlachodimitropoulos D; Linardou H; Samantas E; Pectasides D; Pavlidis N; Fountzilas G
    PLoS One; 2013; 8(7):e70634. PubMed ID: 23923010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan.
    Chen JR; Hsieh TY; Chen HY; Yeh KY; Chen KS; ChangChien YC; Pintye M; Chang LC; Hwang CC; Chien HP; Hsu YC
    Virchows Arch; 2014 Jun; 464(6):689-99. PubMed ID: 24756215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer.
    Garan LAW; Xiao Y; Lin WC
    Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2209211119. PubMed ID: 36252018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors.
    Chantalat E; Boudou F; Laurell H; Palierne G; Houtman R; Melchers D; Rochaix P; Filleron T; Stella A; Burlet-Schiltz O; Brouchet A; Flouriot G; Métivier R; Arnal JF; Fontaine C; Lenfant F
    Breast Cancer Res; 2016 Dec; 18(1):123. PubMed ID: 27927249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
    Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression.
    Chamard-Jovenin C; Jung AC; Chesnel A; Abecassis J; Flament S; Ledrappier S; Macabre C; Boukhobza T; Dumond H
    BMC Syst Biol; 2015 Jun; 9():28. PubMed ID: 26080803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.
    Ooi A; Inokuchi M; Harada S; Inazawa J; Tajiri R; Kitamura SS; Ikeda H; Kawashima H; Dobashi Y
    J Pathol; 2012 May; 227(1):8-16. PubMed ID: 22170254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
    Lin CH; Liu JM; Lu YS; Lan C; Lee WC; Kuo KT; Wang CC; Chang DY; Huang CS; Cheng AL
    J Clin Pathol; 2013 Feb; 66(2):140-5. PubMed ID: 23268322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
    Moelans CB; Monsuur HN; de Pinth JH; Radersma RD; de Weger RA; van Diest PJ
    Anal Cell Pathol (Amst); 2010; 33(1):13-8. PubMed ID: 20966540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
    Holst F; Stahl PR; Ruiz C; Hellwinkel O; Jehan Z; Wendland M; Lebeau A; Terracciano L; Al-Kuraya K; Jänicke F; Sauter G; Simon R
    Nat Genet; 2007 May; 39(5):655-60. PubMed ID: 17417639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
    Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
    Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics.
    Mahboobifard F; Bidari-Zerehpoosh F; Davoudi Z; Panahi M; Dargahi L; Pourgholami MH; Sharifi G; Izadi N; Jorjani M
    Pituitary; 2020 Jun; 23(3):232-245. PubMed ID: 32026205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
    Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
    Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.
    Cochrane DR; Cittelly DM; Howe EN; Spoelstra NS; McKinsey EL; LaPara K; Elias A; Yee D; Richer JK
    Horm Cancer; 2010 Dec; 1(6):306-19. PubMed ID: 21761362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.